Skip to main content
. 2014 Nov 5;91(5):925–935. doi: 10.4269/ajtmh.13-0248

Table 5.

Adverse events reported within the first week of the study*

AL AA
Number of children 104 119
Fever 6 7
Vomiting 2 8
Abdominal pain 5 7
Weakness 0 2
Headache 5 4
Anorexia 5 8
Puffy face 1 2
Abdominal distension 1 1
Cough 14 16
*

Data from two sites.

AL = Artemether-Lumefantrine; AA = Artesunate-Amodiaquine.